Bloodstream Infection Testing Market
Bloodstream Infection Testing Market Forecasts to 2030 - Global Analysis By Product Type (Instruments, Consumables and Software), By Pathogen Type (Bacterial Bloodstream Infections, Fungal Bloodstream Infections and Viral Bloodstream Infections), Testing, Technology, End User and By Geography
|
Years Covered |
2021-2030 |
|
Estimated Year Value (2023) |
US $6.09 BN |
|
Projected Year Value (2030) |
US $11.35 BN |
|
CAGR (2023-2030) |
9.3% |
|
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
|
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
|
Largest Market |
North America |
|
Highest Growing Market |
Asia Pacific |
According to Stratistics MRC, the Global Bloodstream Infection Testing Market is accounted for $6.09 billion in 2023 and is expected to reach $11.35 billion by 2030 growing at a CAGR of 9.3% during the forecast period. Bloodstream infection testing involves diagnostic procedures aimed at identifying microbial pathogens in the bloodstream. This testing utilizes various techniques, including blood cultures and molecular methods, to detect bacteria, viruses, or fungi causing systemic infections. It plays a crucial role in early identification, guiding appropriate treatment decisions and preventing the spread of infections, significantly impacting patient care and public health on a worldwide scale.
According to the U.S. National Library of Medicine, world’s largest medical library, Bloodstream Infections (BSIs) are a leading global cause of disease and mortality. The incidence of BSIs has grown over time and the rates ranges from 122 to 220 cases per 100,000 people.
Market Dynamics:
Driver:
Rising cases of bloodstream infections worldwide
The alarming rise in bloodstream infections (BSIs) across the globe is acting as a potent fuel for the bloodstream infection testing market. This surge is attributed to factors like increasing antibiotic resistance, invasive medical procedures and an aging population that is more susceptible to infections. This growing demand for rapid and precise identification of causative pathogens is driving the market for advanced diagnostic technologies like rapid molecular tests and automated blood culture systems. Additionally, heightened awareness about healthcare-associated infections (HAIs) is prompting hospitals and clinics to invest in robust BSI testing protocols, further propelling the market's expansion.
Restraint:
High costs associated with advanced diagnostic technologies
Advanced diagnostic technologies offer faster and more accurate bloodstream infection testing, their high price tag acts as a major market restraint. These sophisticated tests often require expensive equipment, specialized technicians, and complex workflows, driving up costs for both healthcare providers and patients. This can limit their accessibility in resource-constrained settings and discourage their widespread adoption, hindering the potential benefits they bring to patient care.
Opportunity:
Awareness among healthcare professionals
A crucial opportunity lies in raising awareness among healthcare professionals within the bloodstream infection testing market. Currently, many practitioners lack sufficient knowledge about the latest testing methods or the urgency of early BSI detection. By educating doctors, nurses and other medical staff on the rapid identification and treatment benefits of advanced testing, the market can unlock significant growth potential, which can effectively tap into this lucrative opportunity and drive market expansion.
Threat:
Data security concerns
Bloodstream infection testing relies heavily on digital data, making it vulnerable to cyberattacks. Hackers could steal sensitive patient information or manipulate test results, impacting diagnoses and potentially harming patients. This raises concerns about data privacy, trust in test accuracy and potential legal repercussions that limit market expansion.
Covid-19 Impact:
The COVID-19 pandemic significantly impacted bloodstream infection testing. Medical facilities faced challenges in prioritizing resources for COVID-19 testing, potentially reducing attention to routine testing for bloodstream infections. Additionally, infection control measures, increased patient loads, and altered healthcare practices strained laboratory capacities. Delayed or reduced testing for bloodstream infections during the pandemic might have affected timely diagnosis and treatment, potentially impacting patient outcomes and necessitating adaptations in testing strategies and healthcare delivery.
The instrument segment is expected to be the largest during the forecast period
The instrument segment is poised to secure the largest market share in the market due to the increasing prevalence of bloodstream infections. Automated blood culture systems, molecular diagnostic platforms, and mass spectrometers play pivotal roles in identifying pathogens swiftly. Additionally, continuous advancements in instrument technologies, such as improved sensitivity and specificity, bolster their prominence, making them the leading contributor to the market share for bloodstream infection testing.
The diagnostics laboratories segment is expected to have the highest CAGR during the forecast period
The diagnostics laboratories segment is poised for significant growth due to increased awareness of preventive healthcare and amplified demand for diagnostic services. Technological advancements in diagnostics have led to more accurate and efficient testing methods, attracting more patients. Additionally, the rising prevalence of chronic diseases necessitates regular monitoring, boosting the need for diagnostic center services. Moreover, the COVID-19 pandemic emphasized the importance of accessible and efficient diagnostic facilities, fostering the expansion of diagnostics centers globally.
Region with largest share:
North America's dominance in the bloodstream infection testing market is owing to its advanced healthcare infrastructure and significant investments in research and development. Moreover, the presence of key market players, collaborations between industry and research institutions, and robust regulatory frameworks contribute to market growth. Additionally, the region's proactive adoption of innovative diagnostic technologies and heightened awareness about the importance of infection control further solidify North America's position in securing the largest market share.
Region with highest CAGR:
The Asia-Pacific region is positioned for significant growth due to rapid urbanization, increasing healthcare spending and expanding access to advanced medical technologies. Additionally, a growing population, rising awareness about health issues, and government initiatives supporting healthcare infrastructure development contribute to this trajectory. With a burgeoning middle class and evolving healthcare systems, the Asia-Pacific region presents immense opportunities for market expansion across various industries, including healthcare and diagnostics.
Key players in the market
Some of the key players in Bloodstream Infection Testing Market include Abbott Laboratories, Accelerate Diagnostics, Becton, Dickinson and Company (BD), Biocartis, BioMérieux, Bio-Rad Laboratories, Bruker Corporation, Cepheid, Danaher Corporation, DiaSorin, GenMark Diagnostics, Grifols, Hologic, Inc., Luminex Corporation, Molzym, OpGen, Qiagen, Roche Diagnostics, Sysmex Corporation and Thermo Fisher Scientific.
Key Developments:
In October 2023, Biocartis Group NV (the ‘Company’ or ‘Biocartis’), an innovative molecular diagnostics company and APIS Assay Technologies Ltd. (‘APIS’), a private UK based company specializing in molecular diagnostics, today announced the expansion of their partnership1 to include the commercialization of the APIS ESR1 Mutations Kit through Biocartis’ worldwide commercial network.
In October 2023, Oxford Nanopore Technologies plc (“Oxford Nanopore”), the company delivering a new generation of nanopore-based molecular sensing technology, and bioMérieux SA, a world leader in the field of in vitro diagnostics (“IVD”) announced that bioMérieux is making an immediate £70M investment in Oxford Nanopore.
Product Types Covered:
• Instruments
• Consumables
• Services
Pathogen Types Covered:
• Bacterial Bloodstream Infections
• Fungal Bloodstream Infections
• Viral Bloodstream Infections
Testings Covered:
• Blood Culture Test
• Molecular Diagnostics
• Microbiological Testing
• Immunological Testing
Technologies Covered:
• Conventional Culture Technology
• Mass Spectrometry
• Microarray Technology
• Next-Generation Sequencing (NGS)
• Other Technologies
End Users Covered:
• Hospitals and Clinics
• Diagnostic Laboratories
• Academic and Research Institutes
• Point-of-Care Testing
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Technology Analysis
3.8 End User Analysis
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Bloodstream Infection Testing Market, By Product Type
5.1 Introduction
5.2 Instruments
5.2.1 Automated Blood Culture Systems
5.2.2 Polymerase Chain Reaction (PCR) Instruments
5.3 Consumables
5.3.1 Blood Culture Bottles
5.3.2 Reagents
5.4 Software
5.4.1 Data Analysis Software
5.4.2 Reporting and Interpretation Software
6 Global Bloodstream Infection Testing Market, By Pathogen Type
6.1 Introduction
6.2 Bacterial Bloodstream Infections
6.3 Fungal Bloodstream Infections
6.4 Viral Bloodstream Infections
7 Global Bloodstream Infection Testing Market, By Testing
7.1 Introduction
7.2 Blood Culture Test
7.2.1 Conventional Blood Culture
7.2.2 Automated Blood Culture
7.3 Molecular Diagnostics
7.3.1 Polymerase Chain Reaction (PCR)
7.3.2 Nucleic Acid Amplification Techniques (NAAT)
7.4 Microbiological Testing
7.5 Immunological Testing
8 Global Bloodstream Infection Testing Market, By Technology
8.1 Introduction
8.2 Conventional Culture Technology
8.3 Mass Spectrometry
8.4 Microarray Technology
8.5 Next-Generation Sequencing (NGS)
8.6 Other Technologies
9 Global Bloodstream Infection Testing Market, By End User
9.1 Introduction
9.2 Hospitals and Clinics
9.3 Diagnostic Laboratories
9.4 Academic and Research Institutes
9.5 Point-of-Care Testing
9.6 Other End Users
10 Global Bloodstream Infection Testing Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 New Zealand
10.4.6 South Korea
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Argentina
10.5.2 Brazil
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 UAE
10.6.3 Qatar
10.6.4 South Africa
10.6.5 Rest of Middle East & Africa
11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies
12 Company Profiling
12.1 Abbott Laboratories
12.2 Accelerate Diagnostics
12.3 Becton, Dickinson and Company (BD)
12.4 Biocartis
12.5 BioMérieux
12.6 Bio-Rad Laboratories
12.7 Bruker Corporation
12.8 Cepheid
12.9 Danaher Corporation
12.10 DiaSorin
12.11 GenMark Diagnostics
12.12 Grifols
12.13 Hologic, Inc.
12.14 Luminex Corporation
12.15 Molzym
12.16 OpGen
12.17 Qiagen
12.18 Roche Diagnostics
12.19 Sysmex Corporation
12.20 Thermo Fisher Scientific
List of Tables
1 Global Bloodstream Infection Testing Market Outlook, By Region (2021-2030) ($MN)
2 Global Bloodstream Infection Testing Market Outlook, By Product Type (2021-2030) ($MN)
3 Global Bloodstream Infection Testing Market Outlook, By Instruments (2021-2030) ($MN)
4 Global Bloodstream Infection Testing Market Outlook, By Automated Blood Culture Systems (2021-2030) ($MN)
5 Global Bloodstream Infection Testing Market Outlook, By Polymerase Chain Reaction (PCR) Instruments (2021-2030) ($MN)
6 Global Bloodstream Infection Testing Market Outlook, By Consumables (2021-2030) ($MN)
7 Global Bloodstream Infection Testing Market Outlook, By Blood Culture Bottles (2021-2030) ($MN)
8 Global Bloodstream Infection Testing Market Outlook, By Reagents (2021-2030) ($MN)
9 Global Bloodstream Infection Testing Market Outlook, By Software (2021-2030) ($MN)
10 Global Bloodstream Infection Testing Market Outlook, By Data Analysis Software (2021-2030) ($MN)
11 Global Bloodstream Infection Testing Market Outlook, By Reporting and Interpretation Software (2021-2030) ($MN)
12 Global Bloodstream Infection Testing Market Outlook, By Pathogen Type (2021-2030) ($MN)
13 Global Bloodstream Infection Testing Market Outlook, By Bacterial Bloodstream Infections (2021-2030) ($MN)
14 Global Bloodstream Infection Testing Market Outlook, By Fungal Bloodstream Infections (2021-2030) ($MN)
15 Global Bloodstream Infection Testing Market Outlook, By Viral Bloodstream Infections (2021-2030) ($MN)
16 Global Bloodstream Infection Testing Market Outlook, By Testing (2021-2030) ($MN)
17 Global Bloodstream Infection Testing Market Outlook, By Blood Culture Test (2021-2030) ($MN)
18 Global Bloodstream Infection Testing Market Outlook, By Conventional Blood Culture (2021-2030) ($MN)
19 Global Bloodstream Infection Testing Market Outlook, By Automated Blood Culture (2021-2030) ($MN)
20 Global Bloodstream Infection Testing Market Outlook, By Molecular Diagnostics (2021-2030) ($MN)
21 Global Bloodstream Infection Testing Market Outlook, By Polymerase Chain Reaction (PCR) (2021-2030) ($MN)
22 Global Bloodstream Infection Testing Market Outlook, By Nucleic Acid Amplification Techniques (NAAT) (2021-2030) ($MN)
23 Global Bloodstream Infection Testing Market Outlook, By Microbiological Testing (2021-2030) ($MN)
24 Global Bloodstream Infection Testing Market Outlook, By Immunological Testing (2021-2030) ($MN)
25 Global Bloodstream Infection Testing Market Outlook, By Technology (2021-2030) ($MN)
26 Global Bloodstream Infection Testing Market Outlook, By Conventional Culture Technology (2021-2030) ($MN)
27 Global Bloodstream Infection Testing Market Outlook, By Mass Spectrometry (2021-2030) ($MN)
28 Global Bloodstream Infection Testing Market Outlook, By Microarray Technology (2021-2030) ($MN)
29 Global Bloodstream Infection Testing Market Outlook, By Next-Generation Sequencing (NGS) (2021-2030) ($MN)
30 Global Bloodstream Infection Testing Market Outlook, By Other Technologies (2021-2030) ($MN)
31 Global Bloodstream Infection Testing Market Outlook, By End User (2021-2030) ($MN)
32 Global Bloodstream Infection Testing Market Outlook, By Hospitals and Clinics (2021-2030) ($MN)
33 Global Bloodstream Infection Testing Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
34 Global Bloodstream Infection Testing Market Outlook, By Academic and Research Institutes (2021-2030) ($MN)
35 Global Bloodstream Infection Testing Market Outlook, By Point-of-Care Testing (2021-2030) ($MN)
36 Global Bloodstream Infection Testing Market Outlook, By Other End Users (2021-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
